¨'v . b ó ² 'ö#. b f j í 4) - jpma¥ b. / ; 2018 -104-'¨5'v . b ó ²...
TRANSCRIPT
2018 - 104 -
5
GVP
1
2014 11 25
1993 5
211995
7
1993 11 24999 1994 11 21 1445
31996 51997 4
3
1997 4 25 606
1997 4 25 59
1997 4 25 607
2003 5
2003 5 15
2018 - 105 -
05150052003 5 20
0520004 2003 7
2006 3 24 0324006
IT
2017 6 8 0608-(1)
2017 6 80608-(1)
2019 45
20148 6 0806-(3) GVP
i. 6
ii. PMDA HP
iii.
2014 9 10901-(1) PMDA HP
PMDA HPPMDA
PMDA
PMDA
PMDA2014
9 1
1.1 1)
2018 - 106 -
2
A4 4
2)
3)
1.2
18
19
3 60659 607
0515005 05200042005 4
2005 3 41332006 3 24 0324006
(1)
(2)
(3)
(4)
(5) JAN
(6)
(7)
(8)
(9)
(10)
(11) 606 59607 0515005
0520004 1.3 1.5
(12)
(13)
2018 - 107 -
(14)
(15)
(16)
(17)
(18)
(19)
(20)
1.3
60659 607
0515005 0520004
(1)
(2)
(3)
(4)
(5)
(6)
(7)
6072000 12 25
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
15
7
1
4
2500
WHO
1.4
2018 - 108 -
1988 101988 10 1 853
2002 3 13 170
1.5
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(1)
(2)
(3)
(4)
1.6
20009 19 935
25mg2004 6 2
0602009
2008 9 220922002 0922002
2012 3 310331001 0331001
2014 7 100710-(7) 0710-(5)
2005 9 220922001
2018 - 109 -
20132 14 0214-(1)
2013 8
2005 4
2 20099 5,400
1.7 HP
http://www.e-search.ne.jp/~jpr/
2
2.1
2015 9
662014
2015
2016
2017
2016
2001 10
(RMP)
RMP2017 6 5
4 . 1. GVP
2.2 IFIF
MR MR
MR
2013 42013 10
IF
2018 - 110 -
IFIF PDF
PMDA HP
3
PMDA
2014 11 25
PMDA HP
http://www.pmda.go.jp/files/000144200.pdfPMDA 1 2
PMDAPMDA
5
20 21PMDA
PMDA HPhttp://www.pmda.go.jp/safety/consultation-for-mah/0001.html
GVP
3.11)
2018 - 111 -
PMDA
2014 10 31 1031-(1)
2)
3)
MR
PMDA
PMDA
HP
HPPMDA
4)
1
3.2 1)
3.1 1)
PMDA
2014 10 311031-(1)
2)
3)
2018 - 112 -
MR
PMDA
PMDA
HP
HPPMDA
4)
1
3.3
2014 10 311031-(1) 2015 2 26
1291)
PMDA
PMDA
2)
3)
1) MR
PMDAPMDA
11
4)
3.4
3.5 Pharmaceuticals and Medical Devices
Safety Information
PMDA HP
WHO
1973 62001 6 167
2018 - 113 -
10 PMDA HP
http://www.pmda.go.jp/safety/info-services/drugs/calling-attention/safety-info/0043.html
3.6 DSU: Drug Safety Update
DSUOTC DSU OTC
DSU1992 9
2004 4 No. 128
10 1 19 6
5
OTC DSU OTC2015 11
PMDA HPhttp://www.pmda.go.jp/safety/info-services/dru
gs/calling-attention/dsu/0001.htmlhttp://www.pmda.go.jp/safety/info-services/drugs/calling-attention/dsu/0001.html
3.7
MR
1997 4
1997 6 27 88
200110
4 . 1. GVP
41997
1999 5 PMDAHP
http://www.pmda.go.jp/safety/info-services/drugs/0001.html
RMP
PMDA
SGML (Standard Generalized Markup Language)
PDF (Portable Document Format)
PMDA HP2019 4
SGML XML Extensible Markup Language
2018 - 114 -
20073
2009 5PMDA HP
PMDA
http://www.pmda.go.jp/safety/info-services/medi-navi/0006.html
5
1996 81998 9
1999 8 12
2011 1014
1999 8 12
2011 10 141014-(7) 1014-(8)
2013 3 27 0327-(1)0327-(1)
1991 3 27165 1991 6 3
2002 3 13170 2004 3
31
1652002 4 9 0409001
1991 6 3
1.4 2014 11 25
1.
62 3.2
PMDA HP
2014 8 6 0806-(3)
PMDA2014 9 1 0901-(1)
1.
2018 - 115 -
18
PMS
2018 - 116 -
19
20XX XX XX
Name of Product
)
10.2
3.3.1
< >
3.2
< >
4.
5.
6.
7.
8.
9.9.1
9.2
9.3
9.4
9.5
9.6
9.7
9.8
10.10.1
11.11.111.1.1
11.2
12.
13.
14.
15.15.1
15.2
16.16.1
16.2
16.3
16.4
16.5
1.
mg
20XX XX 20XX XX
2.
2018 - 117 -
16.6
16.7
16.8
17.17.1
17.2
17.3
18.18.1
18.2
19.
20.
21.
22.
23.
24.
25.
26.
2018 - 118 -
20 1
2018 - 119 -
21 2